May26
May 27, 2010 (Datamonitor via COMTEX) Cardiovascular Systems, a medical device company, has enrolled the first patient in its Orbit II investigational device exemption, or IDE, clinical trial to evaluate the safety and effectiveness of its Diamondback 360 system in treating coronary arteries.The patient was treated by PK Khanna, an interventional cardiologist with Eisenhower Medical [...]
Feb10
Copenhagen, 11 February 2010 – Today, at the 5th Annual CHDI Conference onHuntington’s disease, held 8 to 11 February in Palm Springs, California,NeuroSearch (NEUR.CO) presented the results from the MermaiHD study, a PhaseIII study with Huntexil (pridopidine) for the treatment of Huntington’sdisease. Top-line results from the study were announced on 3 February 2010(Announcement no. 01-10),Presenting [...]
Feb10
COPENHAGEN, Denmark, Feb. 10, 2010 (GLOBE NEWSWIRE) Today, at the 5th Annual CHDI Conference on Huntington’s disease, held 8 to 11 February in Palm Springs, California, NeuroSearch (NEUR.CO) presented the results from the MermaiHD study, a Phase III study with Huntexil(r) (pridopidine) for the treatment of Huntington’s disease. Top-line results from the study were [...]